Aim: The aim of this study was to determine the prevalence of GBS serotype distribution in Jos University Teaching Hospital. Materials and Methodology: This was a hospital based descriptive cross-sectional study of 300 women receiving health care at the Jos University Teaching Hospital between July 2017 and November 2017. Systematic sampling technique was employed in recruiting consenting subjects for this study. High vaginal and anorectal swabs were collected from each subject after obtaining their consent by signing a structured consent form. The identified Streptococcus agalactiae (GBS) isolates were serotyped using immuLex strep-B antisera from SSI Diagnostica, 2 Herredysvejen, DK-3400 Hillerod Demnark to identify the different serotypes. The results obtained were computed using SPSS version 21. Samuel et al.; JAMMR, 29(7): 1-7, 2019; Article no.JAMMR.48582 2 Results: A total of 300 women obtaining health care in Jos University Teaching Hospital (JUTH) were enrolled in this study between the months of July, 2017 and November, 2017. In all, vaginal and anorectal swabs were taken from 200 pregnant women and 100 non-pregnant women. The age range of the study population was between 16 years to 48 years with a mean age of 31.9 year (SD ± 6.6). The prevalence rate among the study population was 6.3%. The colonization rate among pregnant and non-pregnant women was 6.5% and 6.0% respectively with no significant statistical difference. Serotype Ia was the commonest isolate responsible for 42.1% of the GBS isolates. Serotype III accounted for 31.6% of the isolates, followed by serotype V (15.8%). Serotype II was less common, responsible for only 10.5%. Conclusion: This study showed that GBS colonization rate among the study population was 6.3%. Approximately, 6.5% and 6.0% prevalence rate were found among pregnant and non-pregnant women respectively. Of all the GBS isolates, serotypes Ia, II, III, and serotype V were isolated with serotype Ia being the most prevalent serotype. This knowledge of serotype distribution will help in instituting serotype specific GBS vaccines for the prevention of GBS diseases in Jos.
INTRODUCTION
Streptococcus agalactiae (Group B Streptococcus, GBS) is a normal flora of the genitourinary tract and the rectum of humans [1] . Streptococcus agalactiae colonizes the human gastrointestinal and genital tracts of 20-30% of healthy humans [2] . The colonization of the vagina by GBS can be transient, chronic or intermittent and serves as potential sources of infection to the new born [3, 4] . From this site, the bacterium can colonize 50% -75% of infants of colonized mothers via the amniotic fluid or the mucous membranes during birth and produce an early onset neonatal disease such as neonatal sepsis, neonatal meningitis, pneumonia 24-48 hours after birth [5, 6] . About 1-2% of the new born of GBS colonized mothers may develop early onset neonatal disease with the maternal genital area serving as source of infection [7, 8] .
Several maternal risk factors can significantly increase the possibility of development of GBS disease in neonates. This is an important fact, since the presence of an isolated risk factor increases the probability that a pregnant woman will have a child with early neonatal GBS disease by 6.5 times [9] . The identification of a high-risk population to be screened for GBS colonization is a considerable challenge, since colonization is also observed in mothers who do not have the classically known risk factors, and it represents 25% to 30% of neonates that develop early neonatal GBS diseases [10] .
GBS colonization rate has been found to be associated with prolonged labour, premature rupture of membrane and preterm delivery [11] . Other factors equally associated with GBS colonization are low levels of circulating maternal antibodies against GBS, maternal age of less than 20 years, and maternal diabetes mellitus [10, 12] .
The frequency of GBS colonization is highest among black women, followed by Hispanic women and white women [10] . However, in some countries, in view of the high degree of racial miscegenation, it is difficult to establish a precise classification of a patient sample in terms of race or ethnic group making it difficult to differentiate among races. Similar study in Saudi Arabia has reported no difference in GBS prevalence among blacks and white Saudi women [13] . One important virulence factor of this GBS is the capsular polysaccharide (CPS). This CPS antigen has been studied extensively and is important antigenic marker. There are ten antigenically distinct serotypes identified, namely Ia, lb, II, III, IV, V, VI, VII, VIII, and IX [14] . Capsular type distribution varies with geographical region and ethnic origin of the population [15] . In the United States and Europe, the most prevalent serotypes in human infections are Ia, II, III, and V, whereas serotypes VI and VIII are the most predominant in Japan [16, 17] .
A study conducted in Gabon revealed that serotypes III and V are the most prevalent serotypes in Gabon similar to what was found in South Africa [18, 19] . There is dearth of knowledge about the Streptococcus agalactiae serotypes in Jos and this study will help reveal the different serotypes distribution. This knowledge of serotype distribution is necessary for the selection and development of serotypebased vaccine for the prevention of invasive disease in a given country [20, 21, 22] .
MATERIALS AND METHODS

Study Area
The study was carried out in Jos University Teaching Hospital (JUTH). Jos University Teaching Hospital is located in Jos the Plateau State capital. The hospital is a tertiary health institution with a 600 beds capacity serving Plateau State and majority of the states in the North-central and part of North-east geopolitical zones of Nigeria. Jos University Teaching Hospital is also a centre for AIDS Prevention Initiative in Nigeria (APIN) that cater for most people leaving with HIV (PLHIV) from within and the bordering states. The main occupation of the people is farming with majority of them in the city being civil servants and businessmen and women.
Study Population
The study population included 200 pregnant and 100 non-pregnant women attending antenatal clinic at the Jos University Teaching Hospital between July 2017 and November 2017.
Study Design
The study was a hospital based descriptive, cross-sectional study were 300 pregnant and non-pregnant women attending antenatal and gynaecology clinics at the Jos University teaching Hospital were recruited consecutively as the came into the clinics by signing a structure consent form.
Sample Collection
Anorectal and vaginal swabs were carefully collected from 200 pregnant women and 100 non-pregnant women using sterile swab sticks by the attending physicians after given them appropriate instructions on how the sample should be collected [23] .
Specimen Transport
The collected specimens were immediately inoculated into a selective enrichment broth, Todd-Hewitt broth (Oxoid LTD) supplemented with gentamycin (8 ug/ml), nalidixic acid (15 ug/ml) and 5% sheep blood to increase the recovery rate of GBS [16, 23] . These were transported to the laboratory within three hours of inoculation.
Culture and Incubation
The tubes of inoculated Todd-Hewitt broth were incubated aerobically at 37°C for 18 to 24 hours. After an overnight incubation, the broths were subcultured onto 10% sheep blood agar and chromatic Strepto B agar (Liofilchem, Italy), a selective medium for GBS.
The inoculated 10% sheep blood agar plates were incubated aerobically in 5-10% CO 2 (candle extinction jar) at 37°C for 18 to 24 hours, while the inoculated chromatic Strepto B agar plates were incubated aerobically at 37°C for 18 to 24 hours [24] . The Streptococcus agalactiae control strain was also inoculated onto 10% sheep blood agar and chromatic Strepto B agar and incubated as stated above respectively.
Identification of GBS Isolates
GBS isolates were identified by their beta haemolytic pattern on 5% sheep blood agar and blue-green colour on chromatic Strepto B agar. The isolates were further subjected to Gram staining, catalase test, and Serogrouping using streptococcal grouping kit (DR0585A OXOID) from Oxoid.
Serotyping of Isolates
The group B B-haemolytic (GBS) isolates were serotyped using immuLexTM strep-B antisera from SS1 Diagnostica, 2 Herredysvejen, DK-3400 Hillerod Denmark to identify the different serotypes according to manufacturer's guidelines.
Data Analysis
The data obtained from the study were analysed using Statistical Package for Social Sciences (SPSS) version 21 (IBM SPSS Inc, USA). Proportions were compared using Chi-square with confidence limit (p-value) of < 0.05 considered significant.
RESULTS
A total of 300 women obtaining health care in Jos University Teaching Hospital (JUTH) were enrolled in this study between the months of July, 2017 and November, 2017. In all, vaginal and anorectal swabs were taken from 200 pregnant women and 100 non-pregnant women. The age range of the study population was between 16 years to 48 years with a mean age of 31.9 years (SD 16.6).
The prevalence rate among the study population was 19(6.3%). The pregnant women were colonized in 6.5% while the colonization rate was 6.0% among the non-pregnant women. The difference in colonization between pregnant and non-pregnant was not statistically significant (Table 1 
DISCUSSION
The study revealed GBS colonization rate of 19(6.3%) among the population tested. The carriage rate was 6.5% in pregnant women and 6.0% in non-pregnant women. This result is lower than the 7.0% previously reported by Nsagha et al. (1997) in Jos [25] . The slight decrease in the colonization rate may be attributed to improve health awareness among the general public and, improvement in culturing technique as Todd-Hewitt broth and chromatic Strepto B agar which are selective media for Streptococcus agalactiae were used in this study making identification and differentiation easy rather than just blood agar.
In The variations between countries could possibly be due, at least in part, to differences in sampling and culturing techniques, types of media used as Well as the population studied [37] . For instance, in this study, samples were collected from HIV positive and HIV negative pregnant women regardless of gestational age.
Serotyping of the GBS isolates revealed that the isolates belong to serotypes Ia, II, III, and V whereas serotypes Ib, IV, VI, VII, VIII and IX were not isolated. As indicated in table above, serotype Ia (42.1%) was the predominant serotype followed by serotype III (31.6%). Serotypes II and V were isolated in 10.5% and 15.8% respectively. The isolated serotypes have been reported as the predominant causes of human infection worldwide [38] and serotype III as the most prevalent and invasive of all the serotypes [39] . Capsular type distribution varies between countries, geographical region and ethnic origin of a population [15] . A study conducted in Gabon revealed that serotype V and III are the most common, which is in consistent with findings in South Africa [18, 19] . Serotypes Ia, Ib and II have been reported in Brazil [40] as the predominant serotypes causing most of the infections there. In United States of America and Europe, serotypes Ia, II, III, and V have been isolated in 80-90% of clinical infections while serotypes VI and VIII are the most predominant in Japan.
This knowledge of serotype distribution is necessary for the selection and development of serotype-based vaccine for the prevention of invasive disease in a given country [20] .
CONCLUSION
This study showed that GBS colonization rate among the study population was 6.3%. Approximately, 6.5% and 6.0% prevalence rate were found among pregnant and non-pregnant women respectively. Of all the GBS isolates, serotypes Ia, II, III, and serotype V were isolated with serotype Ia being the most prevalent serotype. Serotype Ib, IV, VI, VIII and IX were not isolated in this study. This knowledge of serotype distribution will help in instituting serotype specific GBS vaccines for the prevention of GBS diseases in Jos Plateau state, Nigeria.
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